Wordt geladen...
Effects of denosumab on bone metabolism and bone mineral density with anti-TNF inhibitors, tocilizumab, or abatacept in osteoporosis with rheumatoid arthritis
INTRODUCTION: The aim of this 18-month retrospective study was to evaluate the differences in outcomes of denosumab with tumor necrosis factor (TNF) inhibitors (TNFis), tocilizumab (TCZ), or abatacept (ABT) treatment in osteoporosis (OP) patients with rheumatoid arthritis (RA). PATIENTS AND METHODS:...
Bewaard in:
| Gepubliceerd in: | Ther Clin Risk Manag |
|---|---|
| Hoofdauteurs: | , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Dove Medical Press
2018
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5840187/ https://ncbi.nlm.nih.gov/pubmed/29535527 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S156350 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|